Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study

BACKGROUND: Immune checkpoint inhibitors, approved for the treatment of various types of cancer, are known to cause a unique spectrum of side effects, including acute kidney injury (AKI). The aim of this study was to describe the incidence, risk factors, renal outcomes, and mortality of AKI in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Koks, Marije S., Ocak, Gurbey, Suelmann, Britt B. M., Hulsbergen-Veelken, Cornelia A. R., Haitjema, Saskia, Vianen, Marieke E., Verhaar, Marianne C., Kaasjager, Karin A. H., Khairoun, Meriem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186792/
https://www.ncbi.nlm.nih.gov/pubmed/34101756
http://dx.doi.org/10.1371/journal.pone.0252978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186792/
https://www.ncbi.nlm.nih.gov/pubmed/34101756
http://dx.doi.org/10.1371/journal.pone.0252978

Ejemplares similares